4
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0000899243-22-025236
Chief Accounting Officer acquired 10,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Hagen Brett R · Chief Accounting Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-07-01 | Grant or award : show line 1 in the form | +10,500 | 93,578 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-07-01 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +19,500 | 19,500 | D |
Loading xslF345X03/doc4.xml…